A degree containing this module normally requires 4 years for completion.
Admission Requirements
Completion of first-year requirements, including a mark of at least 60% in each of the 3.0 (full or half) principal courses below:
1.0 course: Biology 1001A and 1002B, or the former Biology 1222 or 1223.
1.0 course: Chemistry 1100A/B and 1200B, or the former Chemistry 1020, 1050, or 023.
1.0 course from: Calculus 1000A/B or 1100A/B or 1500A/B, Calculus 1301A/B or 1501A/B, Mathematics 1600A/B or the former Linear Algebra 1600A/B, Mathematics 1225A/B, 1228A/B, 1229A/B, Statistical Sciences 1024A/B, Applied Mathematics 1201A/B or the former Calculus 1201A/B, Applied Mathematics 1413, or the former Mathematics 030.
The following must be completed by the end of second year, with a mark of at least 60% in each half course:
0.5 course from: Physics 1028A/B, 1301A/B or 1501A/B.
0.5 course from: Physics 1029A/B, 1302A/B or 1502A/B.
It is recommended that the two half courses in Physics be taken in the Fall and Winter terms of the same academic year.
Notes for Admission Requirements:
1. Biology 1201A with a mark of at least 70% may be used in place of Biology 1001A, and Biology 1202B with a mark of at least 70% may be used in place of Biology 1002B.
2. Either the former Physics 1020 or 1024 with a minimum mark of 60%, may be used in place of two half courses in Physics listed above.
Module
6.0 courses:
0.5 course: Biochemistry 2280A.
0.5 course: Biology 2382B.
0.5 course: Chemistry 2213A/B.
1.0 course: Physiology 3120.
1.5 courses: Pharmacology 3620 (or the former Pharmacology 3550A/B and 3560A/B) and Pharmacology 3580Y.
1.5 courses in Pharmacology at the 4000-level (with the exception of Pharmacology 4980E).
0.5 course from: Pathology 3240A, 3245B, 4400A/B, Physiology 3140A.
Notes for the Module:
1. Registration in Pharmacology 3580Y requires a minimum average of 75% in the previous year.
2. Students may use Pharmacology 2060A/B in place of one half course in Pharmacology at the 4000-level, provided it was completed prior to September 1, 2012.